ONKAIDO

Serial Number 86174613
606

Registration Progress

Application Filed
Jan 24, 2014
Under Examination
Aug 12, 2014
Approved for Publication
Jun 17, 2014
Published for Opposition
Jun 17, 2014
Registered

Trademark Image

ONKAIDO

Basic Information

Serial Number
86174613
Filing Date
January 24, 2014
Published for Opposition
June 17, 2014
Abandonment Date
September 18, 2017
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 18, 2017
Classes
005

Rights Holder

MODERNATX, INC.

03
Address
320 BENT STREET
CAMBRIDGE, MA 02141

Ownership History

Moderna Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Moderna Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

MODERNATX, INC.

New Owner After Publication #1
03
CAMBRIDGE, MA

Legal Representation

Attorney
Anessa Owen Kramer

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

46 events
Date Code Type Description Documents
Sep 18, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 18, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 11, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 10, 2017 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 8, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 8, 2017 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 2, 2016 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 18, 2016 NOAC E CORRECTED NOA E-MAILED Loading...
Aug 17, 2016 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Aug 12, 2016 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Aug 12, 2016 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Aug 6, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 5, 2016 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 3, 2016 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 3, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 15, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 15, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 22, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2016 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 18, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 10, 2016 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 10, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 29, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 28, 2015 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 27, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 12, 2015 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 12, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 5, 2015 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 5, 2015 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 14, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 12, 2015 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 12, 2015 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 12, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2015 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 12, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 4, 2014 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Aug 1, 2014 APET A ASSIGNED TO PETITION STAFF Loading...
Jul 22, 2014 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Jun 17, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 17, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 28, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 29, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 6, 2014 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 5, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 28, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics and polypeptide therapeutics for use in oncology

Additional Information

Design Mark
The mark consists of the word "ONKAIDO" centered over a dashed line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005